CN101351474A - 抗微生物导管素肽 - Google Patents

抗微生物导管素肽 Download PDF

Info

Publication number
CN101351474A
CN101351474A CNA2006800495652A CN200680049565A CN101351474A CN 101351474 A CN101351474 A CN 101351474A CN A2006800495652 A CNA2006800495652 A CN A2006800495652A CN 200680049565 A CN200680049565 A CN 200680049565A CN 101351474 A CN101351474 A CN 101351474A
Authority
CN
China
Prior art keywords
polypeptide
variant
nucleic acid
seq
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800495652A
Other languages
English (en)
Chinese (zh)
Inventor
T·梅尔加雷霍
F·布勒查
桑永明
M·T·奥尔特加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansas State University
Original Assignee
Kansas State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansas State University filed Critical Kansas State University
Publication of CN101351474A publication Critical patent/CN101351474A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CNA2006800495652A 2005-12-29 2006-12-29 抗微生物导管素肽 Pending CN101351474A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
US60/754,878 2005-12-29

Publications (1)

Publication Number Publication Date
CN101351474A true CN101351474A (zh) 2009-01-21

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800495652A Pending CN101351474A (zh) 2005-12-29 2006-12-29 抗微生物导管素肽

Country Status (8)

Country Link
US (1) US7985832B2 (cg-RX-API-DMAC7.html)
EP (1) EP1966235A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009521932A (cg-RX-API-DMAC7.html)
CN (1) CN101351474A (cg-RX-API-DMAC7.html)
AU (1) AU2006330769A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0621148A2 (cg-RX-API-DMAC7.html)
CA (1) CA2632782A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007076162A2 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109266655A (zh) * 2018-09-06 2019-01-25 浙江大学 一种抗菌肽及其原核表达方法和应用
CN111374169A (zh) * 2019-12-18 2020-07-07 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用
CN111374317A (zh) * 2019-12-18 2020-07-07 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
AU2008205312B2 (en) 2007-01-08 2013-11-21 Annji Pharmaceutical Co., Ltd. Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
MX2010001125A (es) 2007-07-31 2010-09-30 Androscience Corp Composiciones incluyendo receptor androgeno de degradacion (ard) ponteciadores y metodos de tratamiento profilactico o terapeutico de trastornos de la piel y la caida de cabello.
AU2008310076A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag CGRP as a therapeutic agent
KR20100061481A (ko) * 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 미니가스트린
CA2776883A1 (en) * 2009-06-16 2010-12-23 George Mason Intellectual Properties, Inc. Antimicrobial and antibiofilm activity of cathelicidins
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
CN104010653B (zh) 2011-10-31 2019-01-01 凯恩生物科技有限公司 用于预防并治疗口腔疾病的组合物和方法
WO2015196299A1 (en) * 2014-06-27 2015-12-30 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
ES2789351T3 (es) 2015-01-13 2020-10-26 Hope City Máscaras de enlace peptídico de proteínas de unión a CTLA4
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
US20190352377A1 (en) * 2016-11-15 2019-11-21 The Rockefeller University Chimeric antibodies comprising binding domains of phage lysins, bacterial autolysins, bacteriocins, and phage tail or tail fibers
CN109996554B (zh) * 2016-11-21 2024-03-29 匹兹堡大学联邦高等教育系统 新型抗微生物和抗癌疗法
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
CN1878789A (zh) 2003-10-21 2006-12-13 加利福尼亚大学董事会 人凯萨林菌素抗微生物肽
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
EP2200628A2 (en) * 2007-07-15 2010-06-30 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109266655A (zh) * 2018-09-06 2019-01-25 浙江大学 一种抗菌肽及其原核表达方法和应用
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CN111374169A (zh) * 2019-12-18 2020-07-07 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用
CN111374317A (zh) * 2019-12-18 2020-07-07 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Also Published As

Publication number Publication date
US7985832B2 (en) 2011-07-26
EP1966235A4 (en) 2010-01-06
WO2007076162A3 (en) 2008-09-12
AU2006330769A1 (en) 2007-07-05
EP1966235A2 (en) 2008-09-10
US20090221483A1 (en) 2009-09-03
CA2632782A1 (en) 2007-07-05
WO2007076162A2 (en) 2007-07-05
JP2009521932A (ja) 2009-06-11
BRPI0621148A2 (pt) 2011-11-29

Similar Documents

Publication Publication Date Title
CN101351474A (zh) 抗微生物导管素肽
González-Chávez et al. Lactoferrin: structure, function and applications
Tsai et al. Human salivary histatins: promising anti-fungal therapeutic agents
US5948408A (en) DNA encoding bactericidal/permeability-increasing proteins
CA1341525C (en) Biologically active bactericidal/permeability-increasing protein fragments
Gallo et al. Biology and clinical relevance of naturally occurring antimicrobial peptides
Arockiaraj et al. Crustin, a WAP domain containing antimicrobial peptide from freshwater prawn Macrobrachium rosenbergii: immune characterization
Bruhn et al. Antimicrobial peptides and proteins of the horse-insights into a well-armed organism
Sang et al. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide
KR101899552B1 (ko) 전복에서 유래한 항균 펩타이드 유사체 및 이를 포함하는 항균용 약학 조성물
CN114269771B (zh) Romo1来源抗微生物肽及其变体
JP2000513209A (ja) 抗微生物ペプチドと使用方法
WO1995032287A1 (en) Inducible defensin peptide from mammalian epithelia
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
KR20210007075A (ko) 해삼에서 분리한 항균 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR102415725B1 (ko) 신규한 항균 펩타이드 h123 및 이의 용도
Vorland et al. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus
KR102506674B1 (ko) 항생제 내성균에 대한 항균 활성을 가지는 항균 펩타이드 h103b 및 이의 용도
JP2011503137A (ja) 新規のアルギニン置換ペプチド及びその使用
KR101834884B1 (ko) 태평양굴에서 유래한 항균 펩타이드 및 이의 용도
CA2328134A1 (en) The induction of antibiotic proteins and peptides by lait/scd14-protein
Kim et al. Purification and antimicrobial activity studies of the N-terminal fragment of ubiquitin from human amniotic fluid
KR20110018646A (ko) 넙치 유래의 항균성 펩타이드인 베타디펜신을 암호화하는 신규한 유전자 및 그의 용도
CN102264383A (zh) 胞内细菌感染的处理
WO2009121828A1 (en) Use of defensins against meningitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090121